SE9201930D0 - Gastric antibacterial treatment - Google Patents

Gastric antibacterial treatment

Info

Publication number
SE9201930D0
SE9201930D0 SE9201930A SE9201930A SE9201930D0 SE 9201930 D0 SE9201930 D0 SE 9201930D0 SE 9201930 A SE9201930 A SE 9201930A SE 9201930 A SE9201930 A SE 9201930A SE 9201930 D0 SE9201930 D0 SE 9201930D0
Authority
SE
Sweden
Prior art keywords
gastric
antibacterial treatment
treatment
infections
processes
Prior art date
Application number
SE9201930A
Other languages
English (en)
Inventor
K-E Falk
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9201930A priority Critical patent/SE9201930D0/sv
Publication of SE9201930D0 publication Critical patent/SE9201930D0/sv
Priority to IS4030A priority patent/IS4030A/is
Priority to AU45178/93A priority patent/AU4517893A/en
Priority to PCT/SE1993/000521 priority patent/WO1994000112A1/en
Priority to SI9300330A priority patent/SI9300330A/sl

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SE9201930A 1992-06-24 1992-06-24 Gastric antibacterial treatment SE9201930D0 (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9201930A SE9201930D0 (sv) 1992-06-24 1992-06-24 Gastric antibacterial treatment
IS4030A IS4030A (is) 1992-06-24 1993-06-09 Lyf, ætlað til inntöku, sem hefur bakteríueyðandiáhrif í maga, aðferð við framleiðslu þess og notkun
AU45178/93A AU4517893A (en) 1992-06-24 1993-06-11 An oral formulation for gastric antibacterial treatment as well as a process thereof and the use
PCT/SE1993/000521 WO1994000112A1 (en) 1992-06-24 1993-06-11 An oral formulation for gastric antibacterial treatment as well as a process thereof and the use
SI9300330A SI9300330A (sl) 1992-06-24 1993-06-23 Peroralna formulacija za zelodcno protibakterijsko terapijo, postopek izdelave in uporaba

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9201930A SE9201930D0 (sv) 1992-06-24 1992-06-24 Gastric antibacterial treatment

Publications (1)

Publication Number Publication Date
SE9201930D0 true SE9201930D0 (sv) 1992-06-24

Family

ID=20386583

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9201930A SE9201930D0 (sv) 1992-06-24 1992-06-24 Gastric antibacterial treatment

Country Status (5)

Country Link
AU (1) AU4517893A (sv)
IS (1) IS4030A (sv)
SE (1) SE9201930D0 (sv)
SI (1) SI9300330A (sv)
WO (1) WO1994000112A1 (sv)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0995447A1 (en) * 1993-09-09 2000-04-26 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
CA2186785A1 (en) * 1994-04-01 1995-10-12 Yoichiro Nakai Process for producing sustained-release tablets and enteric tablets
CN1096862C (zh) † 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
IL119627A (en) * 1996-11-17 2002-03-10 Yissum Res Dev Co PHARMACEUTICAL PREPARATIONS FOR THE CONTROLLED-RELEASE OF AN ACTIVE AGENT COMPRISING AT LEAST ONE β-LACTAM ANTIBIOTIC AGENT
SE9700885D0 (sv) * 1997-03-12 1997-03-12 Astra Ab New pharmaceutical formulation
ATE286715T1 (de) 1997-03-25 2005-01-15 Takeda Chemical Industries Ltd Gastrointestinale an der mucosa haftende pharmazeutische zusammensetzung
GB9710699D0 (en) * 1997-05-24 1997-07-16 Danbiosyst Uk Gastro-retentive controlled release system
US6694692B2 (en) 1998-10-16 2004-02-24 Francesco Piccone Modular formwork elements and assembly
MXPA05010636A (es) * 2003-04-04 2005-12-12 Pharmacia Corp Comprimidos de multiparticulas preparados por compresion de liberacion oral prolongada.
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
NZ548844A (en) * 2004-01-06 2011-03-31 Panacea Biotec Ltd Controlled release pharmaceutical composition comprising an acid-insoluble polymer and bioadhesive polymer
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
EP1784167A2 (en) * 2004-08-27 2007-05-16 Spherics, Inc. Multi-layer tablets and bioadhesive dosage forms
AU2007230546A1 (en) * 2006-03-24 2007-10-04 Panacea Biotec Ltd. Antibiotic compositions of modified release and process of production thereof
RU2006132127A (ru) * 2006-09-06 2008-03-20 Государственное Учреждение Научный Центр Здоровьядетей Российской Академии Медицинских Наук (Гу Нцзд Рамн) (Ru) Применение нифуроксазида в качестве компонента комбинированной лекарственной терапии заболеваний, ассоциированных с helicobacter pylori, и способ лечения, направленный на эрадикацию возбудителя

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
AU8219191A (en) * 1990-06-14 1992-01-07 Kalmo Enterprises, Inc. Stable aqueous drug suspensions
AU9134791A (en) * 1990-12-11 1992-07-08 Brocades Pharma B.V. Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines

Also Published As

Publication number Publication date
SI9300330A (sl) 1993-12-31
WO1994000112A1 (en) 1994-01-06
AU4517893A (en) 1994-01-24
IS4030A (is) 1993-12-25

Similar Documents

Publication Publication Date Title
SE9201930D0 (sv) Gastric antibacterial treatment
ITBO910476A0 (it) -formulazioni farmeceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali.
DE69802260D1 (de) Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen
MA23533A1 (fr) Formes posologiques d'azithromycine
MX9101046A (es) Anticuerpos novedosos para el tratamiento y prevencion de infeccion de animales y el hombre
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
DK0667148T3 (da) Peroralt farmaceutisk præparat, der udløses i den nedre del af mavetarmkanalen
DE68905939D1 (de) Infektionsresistente zusammensetzungen, medizinische geraete und oberflaechen und verfahren zur herstellung und gebrauch derselben.
ZA895936B (en) Pharmaceutical compositions comprising selected lactobacillus strains
SE0102315D0 (sv) Compounds
NO910213L (no) Fremgangsmaate for fremstilling av orale legemiddelformer av pimobendan.
ZA87164B (en) Opthlamic use of quinolone and naphthyridine antibiotics
DK0616802T3 (da) Oralt præparat til frigivelse i de nedre fordøjelseskanaler
ITRM920900A0 (it) Formulazione proteica coadiuvante nella prevenzione e cura delle parodontiti e di altre patologie batteriche del cavo orale.
AU2000255628A1 (en) Formulation comprising thymol useful in the treatment of drug resistant bacterial infections
HUP9600455A2 (en) Use of quinoxalines combined with protease-inhibiting compounds for producing pharmaceutical compositions for treating aids and/or hiv infections
DE69108143D1 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
DE58903964D1 (de) Fluessige orale formulierung.
TR27833A (tr) Antelmintik'lerin uygulanmasina mahsus ''pour-on'' formülasyonu.
TR199802270A2 (xx) S�lfonamid-ikame etmi� anelize 5-halka-bile�ikleri.
EA200000568A2 (ru) Применение мелатонинергических лигандов для получения фармацевтических композиций, предназначенных для профилактики или лечения патологий желудочно-кишечной системы
WO1999020259A3 (en) Compositions containing thiamphenicol and diclofenac
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
DE69737088D1 (de) Therapeutisches agens zur behandlung von fiv infektionen
ATE145333T1 (de) Hirudin enthaltende orale arzneimittel